1. Cancer Chemotherapy Update: Mesna, Doxorubicin, Ifosfamide, and Dacarbazine (MAID) Regimen for Sarcomas
- Author
-
Dominic A. Solimando and J. Aubrey Waddell
- Subjects
Pharmacology ,Oncology ,medicine.medical_specialty ,Ifosfamide ,Cancer chemotherapy ,business.industry ,Dacarbazine ,Pharmacy ,030226 pharmacology & pharmacy ,Doxorubicin/ifosfamide ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Pharmacology (medical) ,030212 general & internal medicine ,MAID Regimen ,business ,medicine.drug ,Mesna - Abstract
The increasing complexity of cancer chemotherapy now requires that pharmacists be familiar with these highly toxic agents. This column will review various issues related to preparation, dispensing, and administration of cancer chemotherapy, and review various agents, both commercially available and investigational, used to treat malignant diseases. The views expressed in this article are those of the author(s) and do not reflect the official policy of the Department of Army, Department of Defense, or US Government.
- Published
- 2007
- Full Text
- View/download PDF